Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

International forum on Occult hepatitis B infection and transfusion safety.

Seed CR, Allain JP, Lozano M, Laperche S, Gallian P, Gross S, Kwon SY, Oh EY, Kim JN, Chua SS, Lam S, Ang AL, Tsoi WC, Hewitt PE, Davison K, Tettmar K, O'Flaherty N, Boland F, Williams P, Pomeroy L, Wendel S, Fachini R, Scuracchio PSP, Carminato P, Fearon M, O'Brien SF, Delages G, Kiely P, Hoad VC, Matsubayashi K, Satake M, Taira R, Stramer SL, Sauleda S, Bes M, Piron M, Ekiaby ME, Vermeulen M, Stezinar SL, Nograšek P, Jarvis LM, Petrik J, Charlewood R, Flanagan P, Grabarczyk P, Kopacz A, Łętowska M, Schmidt M, Seifried E.

Vox Sang. 2019 May;114(4):397-406. doi: 10.1111/vox.12744. Epub 2019 Feb 28. No abstract available.

PMID:
30818422
2.

International Forum on Occult hepatitis B infection and transfusion safety.

Seed CR, Allain JP, Lozano M, Laperche S, Gallian P, Gross S, Kwon SY, Oh EY, Kim JN, Chua SS, Lam S, Ang AL, Tsoi WC, Hewitt PE, Davison KL, Tettmar K, O'Flaherty N, Boland F, Williams P, Pomeroy L, Wendel S, Fachini R, Scuracchio P, Carminato P, Fearon M, O'Brien SF, Delage G, Kiely P, Hoad V, Matsubayashi K, Satake M, Taira R, Stramer SL, Sauleda S, Bes M, Piron M, El Ekiaby M, Vermeulen M, Levičnik Stezinar S, Nograšek P, Jarvis LM, Petrik J, Charlewood R, Flanagan P, Grabarczyk P, Kopacz A, Łętowska M, Seifried E, Schmidt M.

Vox Sang. 2019 May;114(4):e1-e35. doi: 10.1111/vox.12743. Epub 2019 Apr 10. No abstract available.

PMID:
30972757
3.

[Progress in research of occult hepatitis B virus infection].

Huang XY, Shi QF, Huang T.

Zhonghua Liu Xing Bing Xue Za Zhi. 2017 May 10;38(5):688-692. doi: 10.3760/cma.j.issn.0254-6450.2017.05.027. Chinese.

PMID:
28651413
4.

Occult hepatitis B virus infection and blood transfusion.

Seo DH, Whang DH, Song EY, Han KS.

World J Hepatol. 2015 Mar 27;7(3):600-6. doi: 10.4254/wjh.v7.i3.600. Review.

5.

Occult Hepatitis B virus infection in previously screened, blood donors in Ile-Ife, Nigeria: implications for blood transfusion and stem cell transplantation.

Olotu AA, Oyelese AO, Salawu L, Audu RA, Okwuraiwe AP, Aboderin AO.

Virol J. 2016 May 5;13:76. doi: 10.1186/s12985-016-0533-3.

6.

The clinical significance of occult hepatitis B transfusion in Taiwan--a look-back study.

Su TH, Chen PJ, Chen TC, Cheng HR, Li L, Lin KS, Kao JH, Chen DS, Liu CJ.

Transfus Med. 2011 Feb;21(1):33-41. doi: 10.1111/j.1365-3148.2010.01036.x. Epub 2010 Aug 18.

PMID:
20726954
7.

Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in Taiwan.

Liu CJ, Lo SC, Kao JH, Tseng PT, Lai MY, Ni YH, Yeh SH, Chen PJ, Chen DS.

J Hepatol. 2006 Jan;44(1):39-46. Epub 2005 Jul 12.

PMID:
16168517
8.

Occult hepatitis B infection and transfusion-transmission risk.

Candotti D, Boizeau L, Laperche S.

Transfus Clin Biol. 2017 Sep;24(3):189-195. doi: 10.1016/j.tracli.2017.06.014. Epub 2017 Jun 30. Review.

PMID:
28673499
9.

Post-transfusion occult hepatitis B (OBI): a global challenge for blood recipients and health authorities.

Arababadi MK, Hassanshahi G, Pourfathollah AA, Zarandi ER, Kennedy D.

Hepat Mon. 2011 Sep;11(9):714-8. doi: 10.5812/kowsar.1735143X.694.

10.
11.

Prevalence of occult HBV among hemodialysis patients in two districts in the northern part of the West Bank, Palestine.

Dumaidi K, Al-Jawabreh A.

J Med Virol. 2014 Oct;86(10):1694-9. doi: 10.1002/jmv.24008. Epub 2014 Jul 3.

PMID:
24992542
12.

Occult hepatitis B virus infection of hemodialysis patients: a cross-sectional study in a hepatitis B virus-endemic region.

Kim SM, Kim HW, Lee JE, Lee EK, Shin HD, Song IH.

Hemodial Int. 2015 Jan;19(1):66-71. doi: 10.1111/hdi.12214. Epub 2014 Sep 5.

PMID:
25196802
13.

Occult hepatitis B virus infection and its clinical implications.

Hu KQ.

J Viral Hepat. 2002 Jul;9(4):243-57. Review.

PMID:
12081601
14.

The role of anti-core antibody response in the detection of occult hepatitis B virus infection.

Urbani S, Fagnoni F, Missale G, Franchini M.

Clin Chem Lab Med. 2010;48(1):23-9. doi: 10.1515/CCLM.2010.002. Review.

PMID:
19919328
15.

Poor efficacy of nucleic acid testing in identifying occult HBV infection and consequences for safety of blood supply in Italy.

Spreafico M, Berzuini A, Foglieni B, Candotti D, Raffaele L, Guarnori I, Colli A, Maldini FF, Allain JP, Prati D.

J Hepatol. 2015 Nov;63(5):1068-76. doi: 10.1016/j.jhep.2015.06.016. Epub 2015 Jun 24.

PMID:
26116791
16.

Occult hepatitis B virus infection: a complex entity with relevant clinical implications.

Larrubia JR.

World J Gastroenterol. 2011 Mar 28;17(12):1529-30. doi: 10.3748/wjg.v17.i12. 1529.

17.

Occult hepatitis B: the Egyptian situation.

Emara MH.

Trop Gastroenterol. 2012 Oct-Dec;33(4):242-50. Review.

PMID:
23923349
18.

Transfusion-transmitted hepatitis B virus infection.

Candotti D, Allain JP.

J Hepatol. 2009 Oct;51(4):798-809. doi: 10.1016/j.jhep.2009.05.020. Epub 2009 Jun 10. Review.

19.

An overview of occult hepatitis B virus infection.

Said ZN.

World J Gastroenterol. 2011 Apr 21;17(15):1927-38. doi: 10.3748/wjg.v17.i15.1927. Review.

20.

Occult hepatitis B virus infection as a cause of posttransfusion hepatitis in patients with cancers.

Sodhi JS, Wani N, Jeelani S, Geelani S, Akhtar F, Javid G, Yattoo GN, Shah A, Gulzar GM, Khan MA, Parveen S, Saif RU, Showkat A.

Indian J Gastroenterol. 2013 Sep;32(5):291-6. doi: 10.1007/s12664-013-0323-4. Epub 2013 Mar 20.

PMID:
23512211

Supplemental Content

Support Center